grant

TRD1: Functional Imaging

Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 21 Jul 2011Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY20263-D3-D Imaging3-Dimensional3D3D imagingAccelerationAddressAdvanced DevelopmentAngiogramAngiographyAnimal ModelAnimal Models and Related StudiesAnimalsAxonBiologicalBlood VesselsBlood capillariesBody TissuesCaliberCell Communication and SignalingCell SignalingClinicalCommunitiesDataDevelopmentDiabetic RetinopathyDiagnosisDimensionsDiseaseDisorderEarly DiagnosisFunctional ImagingGlaucomaHumanImageImaging ProceduresImaging TechnicsImaging TechniquesIndividualIntracellular Communication and SignalingMS treatmentMethodsMiceMice MammalsModalityModern ManMonitorMurineMusNeuroprotectantsNeuroprotective AgentsNeuroprotective DrugsOCT angiographyOCTAOphthalmologyOpticsPathway interactionsPerfusionPhysicsPhysiologic ImagingPupilResearchResolutionRetinaRodent ModelSamplingSignal TransductionSignal Transduction SystemsSignalingStructureTOMOTechniquesTechnologyThree-Dimensional ImagingTissuesTomogramTranslationsTumor BiologyVisualizationadaptive opticsangiogenesisangiographic imaginganimal imagingaxonal degenerationbiologicbiological signal transductioncancer microenvironmentcapillaryclinical applicabilityclinical applicationdegenerative axondensitydevelopmentaldisease modeldisorder modelearly detectionglaucomatoushigh definitionhigh-resolutionimagingimprovedin vivointerestlight scatteringmodel of animalmultiple sclerosis therapymultiple sclerosis treatmentnovelopticaloptical coherence tomography angiographypathwayphysiological imagingpolarimetrypre-clinicalpreclinicalpreservationresolutionsretinal axonretinal imagingsignal processingthree dimensionaltooltranslationtumor microenvironmentvascularvirtual
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
TRD 1

The overarching theme of TRD 1 is to develop powerful new tools for functional imaging: specifically, the devel-

opment of advanced post-processing methods to 1) enhance endogenous contrast in polarization-sensitive

OCT tissue polarimetry, and 2) transform OCT angiography from a pseudo- to a fully-3D technique by dramati-

cally improving its cross-sectional quality and depth resolution. Current post-processing in OCT polarimetry

(PS-OCT) and angiography (OCTA) imparts significant resolution loss—roughly one order of magnitude—gen-

erating contrast with poor spatial resolution compared to the originating OCT data. There is a need for process-

ing techniques capable of preserving spatial resolution to enable a broad range of applications that are

presently outside the reach of OCT technology. This project will develop a probabilistic processing framework

based on the physics of light scattering and OCT image formation that leverages from the similarity of func-

tional signals typically present in biological sample tomograms. This framework will allow for estimation of the

underlying structure and associated contrast—or function—without compromising spatial resolution.

Aim 1 addresses the need for high-resolution cross-sectional polarimetric imaging of the living retina. Proba-

bilistic PS-OCT offers a new pathway to preserve the originating hardware’s resolution, alleviating the need for

increased optical resolution, limited by pupil size in human and animals and accompanied by an impractical re-

duction in the depth of field. This novel capability, combined with PS-OCT hardware equipped with adaptive op-

tics, will enable the determination of polarimetric parameters of individual axonal bundles in the retina. It will

permit PS-OCT to sensitively track retinal axonal degeneration in vivo, thus accelerating the development of

neuroprotective agents for the treatment of multiple sclerosis that rely on rodent models of this disease.

Aim 2 addresses the need to improve the spatial resolution and quality of OCTA in both preclinical and clinical

applications by further extending the probabilistic framework to the OCT signal dynamics. OCTA is also show-

ing significant promise in ophthalmology for the potential use in the early diagnosis and monitoring of diseases

including glaucoma and diabetic retinopathy; preclinical use include imaging animal models to improve under-

standing of tumor biology. However, its poor cross-sectional quality and resolution restricts OCTA to a pseudo-

3D imaging technique, with a depth resolution most commonly four to eight times poorer than in the originating

OCT tomogram, thus limiting angiographic analysis to en face and layer projections in virtually all applications.

Probabilistic OCTA will improve the lacking depth resolution of conventional OCTA, overcoming the insensitivity

to small capillaries and the distortion of true vessel dimensions, which currently undermine caliber and vascu-

lar-network quantitative metrics of great clinical interest in ophthalmology. OCTA with high cross-sectional qual-

ity would amplify its utility in the understanding of the three-dimensional tumor microenvironment, and unlock

the power of volumetric vascular-network metrics in preclinical and clinical applications.

Grant Number: 5P41EB015903-15
NIH Institute/Center: NIH

Principal Investigator: Brett Bouma

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →